Active Ingredient: DROSPIRENONE; ETHINYL ESTRADIOL
Proprietary Name: KYRA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 3MG;0.02MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A202318
Product Number: 001
Approval Date: Jul 23, 2019
Applicant Holder Full Name: SUN PHARMACEUTICAL INDUSTRIES LTD
Marketing Status:
Discontinued
Patent and Exclusivity Information
